The authors discuss clinical and international experience about botulinum toxins (BTX types A and B) in headache treatment. Data from literature suggest good results for the treatment of tension-type headache, migraine and chronic tension-type headache. In the present paper mechanisms of action and injection sites will also be discussed.
No takes yet. Share an insight, caveat, or question.
Porta et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: